TERUMO CORPORATION 
TOKYO, JAPAN - December 15, 2016 -- Terumo Corporation (TSE: 4543) hereby announces that its Board of Directors meeting held on December 15, 2016 has resolved the appointments of a new CEO, and new Chairman of the Board as indicated below.
Reason for the Appointment: Terumo Corporation has decided to transition to a new management team in order to accelerate execution of core strategies outlined in the new five-year Mid- to Long-term Growth Strategy starting from April 1, 2017.
Details of the Appointment
New Title
Name
Current Title
Chairman of the Board (Representative Director)
Takayoshi Mimura
Director and Senior Managing Executive Officer
President and CEO (Representative Director)
Shinjiro Sato
Director and Managing Executive Officer
Scheduled Date of Assumption of Office: April 1, 2017
[Profile of Newly Appointed Chairman] Name Takayoshi Mimura
Date of Birth June 18, 1953 Birthplace Osaka, Japan
Education March 1977 Graduated from Kansai University (Sociology)
Business Experience
April 1977 Joined Terumo Corporation June 2002 Executive Officer
June 2003 Director and Executive Officer
June 2004 Director and Senior Executive Officer June 2007 Director and Managing Executive Officer
April 2008 Group President of General Hospital Business Group Responsible for Domestic Sales Dept.
June 2009 Regional Representative, China and Asia April 2010 Regional Representative, China (present)
June 2010 Director and Senior Managing Executive Officer (present) August 2011 President and CEO, Terumo (China) Holding Co., Ltd.
April 2014 Responsible for Terumo Call Center Numbers of Shares Held 20,065
[Profile of Newly Appointed President] Name Shinjiro Sato
Date of Birth July 19, 1960 Birthplace Tokyo, Japan
Education March 1984 Graduated from the University of Tokyo (Economics) May 1988 Graduated from Duke University (MBA)
Business Experience
April 1984 Joined Toa Nenryo Kogyo K.K. (present Tonen General Sekiyu K.K.) February 1999 Joined Arthur Andersen Business Consulting (present PwC Japan Group) June 2004 Joined Terumo Corporation
June 2010 Executive Officer
General Manager of Strategic Planning Dept.
October 2011 Group President of Cardiac and Vascular Business Group (currently, President, Cardiac and Vascular Company) (present)
June 2012 Senior Executive Officer
June 2014 Director and Senior Executive Officer
April 2015 Director and Managing Executive Officer (present) Numbers of Shares Held 8,165
About Terumo Corporation Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol , or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.###
Terumo Corporation published this content on 15 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 December 2016 09:55:55 UTC.
Original documenthttp://www.terumo.com/about/pressrelease/2016/20161215.pdf
Public permalinkhttp://www.publicnow.com/view/3E3C51805BDA0B9EAB6F9B059E4632DDE11AD29A
